FDA approves Moderna’s first-ever mRNA flu shot despite 75.3% adverse reaction rate In a dark day for MAHA, the FDA has approved Moderna’s mFLUSIVA for adults 50 and older, making it the first seasonal mRNA influenza injection authorized in the United States. Adults ages 50–64 received traditional approval, while adults 65 and older received accelerated
By Z Miller/SAGE Journals The infant mortality rate (IMR) is one of the most important indicators of the socio-economic well-being and public health conditions of a country. The US childhood immunization schedule specifies 26 vaccine doses for infants aged less than 1 year—the most in the world—yet 33 nations have lower IMRs. Using linear regression,
Check out our latest book exposing the great lies: Hope Amidst a Tsunami of Evil Flight attendant dies of a heart attack while in the air: Gulf Air jet makes emergency landing while en route from Bahrain to Paris Air steward Yasser Saleh Al Yazidi was taken ill on a Gulf Air flight last week.
The myth of stopping Covid-19 transmission via vaccination—public Perception is massively skewed By Ivan Fraser Having been exposed to this kind of messaging for decades, people have been persuaded to believe that vaccines stop transmission of common respiratory viruses, despite science to the contrary. Essentially, the messaging is marketing. “By having the flu jab you
Transcript: It’s July 2022 and this is video number 315. I want to tell you how a brand new novel flu vaccine is being tested because I think you should know. And because I think it shines a bright light on how new drugs and vaccines are tested. And because I think something very, very